Stereotactic radiotherapy and pembrolizumab for kidney cancer
Results from the phase 1/2 RAPPORT trial show that stereotactic [...]
Results from the phase 1/2 RAPPORT trial show that stereotactic [...]
We have just learnt that the Committee for Medicinal Products [...]
The Food and Drug administration (FDA) in the USA has [...]
Treatment of people with intermediate to high risk renal cell [...]
Non-clear cell RCC is about 20-25% of all RCC diagnoses [...]
KEYNOTE-427 is an open-label, single-arm, phase II study to look [...]
Adjuvant therapy is medication that is given in addition to [...]
In this video, Dr Bradley McGregor from the Dana-Farber Cancer [...]
The US Food and Drug Administration (FDA) has approved the [...]
Results from a phase Ib/II study looking at lenvatinib plus [...]